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ABSTRACT 
The microanatomy of immune clearance of infected brain cells remains poorly understood. 
Immunological synapses are essential anatomical structures that channel information exchanges 
between T cell–antigen-presenting cells (APC) during the priming and effector phases of T cells' 
function, and during natural killer–target cell interactions. The hallmark of immunological synapses 
established by T cells is the formation of the supramolecular activation clusters (SMACs), in which 
adhesion molecules such as leukocyte function-associated antigen 1 segregate to the peripheral 
domain of the immunological synapse (p-SMAC), which surrounds the T cell receptor–rich or central 
SMAC (c-SMAC). The inability so far to detect SMAC formation in vivo has cast doubts on its 
functional relevance. Herein, we demonstrate that the in vivo formation of SMAC at immunological 
synapses between effector CD8+ T cells and target cells precedes and mediates clearance of virally 
infected brain astrocytes. 
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INTRODUCTION 
Immunological synapses are thought to be the anatomical manifestation of intercellular 
communication in the immune system (1). Immunological synapses serve as the anatomical 
substrate of T cell–APC communication during the priming of naive T cells and during the effector 
phase of T and NK cells' function (1–6). The molecular components of immunological synapses differ 
between those established by T cells or NK cells. The essential feature of mature immunological 
synapses formed by T cells is the distinctive “bull's eye” structure, (1, 3–6) a specialized intercellular 
junction formed by the central supramolecular activation cluster (c-SMAC) containing TCR binding to 
peptide-MHC, surrounded by a ring (peripheral SMAC [p-SMAC]) containing a high density of 
adhesion molecules such as leukocyte function-associated antigen 1 (LFA-1), and intercellular 
adhesion molecule 1 (ICAM-1) (1–8). LFA-1 is associated with Talin in the p-SMAC (6, 9) and activates 
integrin signaling to link the immunological synapse and the cytoskeleton (7). So far, immunological 
synapses have only been characterized in culture systems (1–8). 
Homogeneous populations of antigen-specific T cells coincubated with epitope-loaded APCs in vitro 
(6, 8–12) or with artificial planar bilayers (4, 13) have been examined either continuously over time, 
using live cells imaged with a cooled charge-coupled device camera, or after fixation, using confocal 
laser scanning microscopy to characterize the structure and kinetics of c- SMAC and p-SMAC at the 
immunological synaptic interface. 
T cell interactions with APCs are dynamic and formation of the mature immunological synapse is the 
culmination of TCR activation. Immunological synapses are thought to facilitate TCR signaling by 
concentrating TCRs binding to peptide-MHC. TCR activation stimulates a tyrosine kinase cascade that 
results in Lck and ZAP-70 phosphorylation, rapid activation of phospholipase Cγ, generation of 
inositol-polyphosphates, Ca2+ mobilization, and T cell activation (8, 10–12, 14) (for review see 
reference 1). 
However, the physiological relevance of immunological synapses has been challenged by kinetic 
analyses that show a dissociation between synapse formation from effector function (15–17) and 
the lack of evidence so far for their in vivo existence during immune responses in a living organism 
(for a detailed discussion on the status of immunological synapses, see reference 1). Nevertheless, 
very recent data demonstrate that one of the physiological functions of immunological synapses is to 
direct cytokine secretion vectorially either directly into the synapse, or in a multidirectional manner 
outside the synapse (18). This work illustrates how immunological synapses implement the vectorial 
transfer of information, as neuronal synapses are known to do. 
Here, we show that preceding and during the clearance of virally infected cells, effector CD8+ T cells 
infiltrate specifically the brain area containing infected astrocytes. CD8+ T cells establish mature 
immunological synapses composed of both the c- and p-SMAC. Immunological synapse formation 
precedes the clearance of infected astrocytes. In CD8+ T cells contacting infected targets, tyrosine 
kinases Lck and ZAP-70 became phosphorylated and polarized toward the synaptic interface, a result 
of TCR activation that leads to T cell activation (8, 10–12, 14) (for review see references 1, 19). 
Although previous in vivo studies failed to detect mature immunological synapses, our data 
demonstrate the characteristic segregation of adhesion molecules, TCR, and signaling molecules 
within effector T cells that adopt the typical structures of mature immunological synapses containing 
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c- and p-SMAC. This proves their immunological significance during the clearance of infected cells in 
a living organism. 
 
RESULTS 
Clearance of infected astrocytes from the brain 
To visualize the detailed microanatomy of brain immunological synapses, we set up an experiment in 
which T cells would selectively target virally infected brain astrocytes. To do so, nonreplicating 
adenoviral vectors were chosen to infect brain cells within a restricted site within the rat brain (i.e., 
the striatum) and infected cells were identified through expression of a reporter gene encoded 
within the vector (e.g., HSV1-thymidine kinase [TK]). More than 85% of infected cells were GFAP-
expressing astrocytes (Fig. 1 A). 30 d later, animals were immunized with a systemic injection of RAd-
HPRT (20), an adenovirus encoding an unrelated transgene to that expressed in the brain, to 
stimulate a specific systemic immune response against adenovirus. The systemic administration of 
adenovirus is needed because the initial delivery of a nonreplicating adenovirus to the brain 
parenchyma fails to prime a systemic immune response against adenovirus (or other infectious 
antigens), as a result of the so-called immune privilege of the brain (20–23). A replication-deficient 
adenovirus was used to avoid any interference from viral replication on cell viability. In this model, 
cell loss is exclusively immune mediated, rather than as a result of viral replication. 
Systemic immunization against adenovirus causes a specific infiltration of the brain injection site 
with T cells, and clearance of TK-expressing astrocytes and adenoviral genomes from the striatum 
(Figs. 1 B and and2).2). Astrocytes displayed MHC-I on their plasma membrane, thus constituting a 
potential target for activated CD8+ T cells (24) (Fig. 1 C). Selective antibody depletion of CD4+ and 
CD8+ T cells 3 d after the systemic immunization demonstrated that both were necessary for 
astrocyte clearance (Fig. 3). That each type of T cell makes a separate contribution to clearance was 
shown by the fact that CD4+ T cells remained confined to the perivascular compartment (Fig. 2), 
whereas CD8+ T cells did infiltrate the site within the brain parenchyma proper where infected 
astrocytes were located (Fig. 2). CD8+ T cells also established frequent close anatomical contacts 
with infected brain cells (Fig. 2, c–f). CD8+ T cells' influx into the central nervous system (CNS) 
reached its peak at 14 d after immunization, whereas the loss of infected cells occurred between 14 
and 30 d (Figs. 1 and and3).3). The analysis of brain immunological synapses in vivo is based on the 
detailed study of brains from 25 rats and a total of at least 60 immunological synapses that were 
thoroughly studied in detail. 
Initial stages in the formation of immunological synapses in vivo 
Polarization of phosphorylated tyrosine kinases, the initial stages in the formation of immunological 
synapses in vivo, can be detected preceding and throughout the clearance of infected astrocytes by 
CD8+ T cells. To further characterize immune–target cell interactions and the activation of T cells, we 
studied the distribution of phosphorylated Lck and ZAP-70 in CD8+ T cells contacting target 
astrocytes. Engagement of the TCR on CD8+ T cells by MHC-I peptide complexes present on the 
surface of target APCs activates effector T cells and stimulates the T cell tyrosine kinase signaling 
cascade (10, 11, 14). Tyrosine kinase signaling activation was assessed by immunocytochemistry 
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using antibodies recognizing specifically active, phosphorylated-Lck (p-Lck) (recognizing pY394), or 
active, phosphorylated-ZAP-70 (p-ZAP-70) (recognizing pY319) (10, 11, 14, 25). 
Phosphorylated-Lck and p-ZAP-70 were polarized in CD8+ T cells to sites of close membrane 
apposition between CD8+ T cells and target astrocytes only in the virally injected hemisphere (Figs. 4 
and and5).5). Phosphorylation of tyrosine kinases precedes the establishment of mature 
immunological synapses. Thus, we studied the anatomical arrangements of these early sites of T 
cell–astrocyte interactions through serial reconstruction appositions identified with the confocal 
microscope, and three-dimensional artistic rendering of the confocal images (Figs. 4 B and 5 B). Most 
CD8+ T cells displayed a single site of close membrane apposition with astrocytes (Fig. 4, A and B), 
although in some cases a CD8+ T cell would make up to three such polarized contacts with a single 
target astrocyte (Fig. 5). CD8+ T cells formed complex close interactions with target astrocytes. T 
cells either surrounded the target cell's processes (Fig. 5 B [b, d, and e]) or displayed cytoplasmic 
evaginations that appeared to press into the target cell body (Fig. 5 B [c, f, and g]). Thus, brain-
infiltrating CD8+ T cells increased TK cascade phosphorylation induced by TCR signaling (i.e., Lck and 
ZAP-70), indicating that the CD8+ T cells were activated through interaction with antigenic peptides 
on MHC-I expressed on astrocytes (Fig. 1 C). Polarization of phosphorylated TKs at contacts between 
CD8+ T cells and target astrocytes strongly implied the visualization of immunological synapse 
formation in progress. 
SMAC formation during the maturation of immunological synapses in vivo 
To determine whether mature immunological synapses containing c-SMAC and p-SMAC develop at 
the CD8+ T cell–astrocyte junctions previously shown to contain polarized tyrosine kinases, we 
studied the distribution of LFA-1 and TCR on T cells participating potentially in the formation of 
immunological synapses; we used TK as a marker of virally infected cells. The analysis of LFA-1 and 
TCR expression in T cells not in contact with infected cells showed a homogeneous, nonpolarized 
distribution (Fig. 6). The distribution of LFA-1 and TCR at the T cell membrane closely apposed to 
infected target astrocytes clearly indicated the formation of p-SMAC (LFA-1 rich, TCR poor) and c-
SMAC (LFA-1 poor, TCR rich) in vivo (Figs. 7 and and8).8). This indicates that T cell–astrocyte 
junctions mature to form proper immunological synapses with SMAC formation, concomitantly with 
the influx of CD8+ T cells into the brain, and preceding the clearance of virally infected astrocytes. 
The optical images obtained with the confocal microscope were further analyzed using custom-
made three-dimensional reconstruction software. Images were α blended to perform a three-
dimensional reconstruction from the two-dimensional serial images. This model was rotated in three 
dimensions, and reconstructions were used to examine in detail the microanatomy of mature brain 
immunological synapses at the interface plane (Figs. 7–99). 
At the interface plane, the p-SMAC is characterized by an LFA-1–immunoreactive ring (Figs. 7–99)) 
surrounding a central area of increased TCR immunoreactivity (Figs. 7–99)) and low or absent LFA-1 
(Figs. 7, ,8,8, and and10).10). Note that in most cases LFA-1 immunoreactivity increases within the p-
SMAC (Fig. 10, D, G, and I), whereas in others there is a drop in c-SMAC LFA-1 (Fig. 10, F, H, and E); 
both distributions provide a p-SMAC–rich/c-SMAC–poor LFA-1 pattern. Finally, in those T cells 
forming mature immunological synapses, we observed that T cells' nuclei displayed a polarized notch 
open toward the immunological synapse, indicating that the whole structure of T cells polarized 
toward the immunological synapse (Fig. 8, A and E). 
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DISCUSSION 
In this study, we have shown that CD8+ T cells form typical immunological synapses in vivo 
displaying p- and c-SMAC at the interface with virally infected astrocytes, preceding and during the 
clearance of infected cells from the brain. We do so in a model of immune-mediated clearance of 
infected astrocytes, and demonstrate that both CD8+ T cells and CD4+ T cells are necessary parts of 
the effector arm of the immune response, possibly as CD4+ Th1 cells. However, detailed 
morphological analysis demonstrated that CD4+ T cells remain circumscribed to the perivascular 
compartment, whereas CD8+ T cells enter the brain parenchyma and form close anatomical contacts 
with infected cells. A likely explanation is that CD4+ T cells may aid in the entry of CD8+ T cells into 
the brain; this is similar to the strategies adopted by both CD4+ and CD8+ T cells during the 
clearance of MHV from the brain (26). 
Although both cell types peak at an early time point in the lymph nodes, it is likely that differential 
chemokine and adhesion molecule expression by CD4+ T cells determines their delayed migration to 
the CNS and their selective perivascular accumulation when compared with CD8+ T cells (27–30). 
The delayed peak of intracranial CD4+ T cells may serve to facilitate the entry of macrophages into 
the CNS (31). 
Initial TCR activation leads to the specific stimulations of the TK signaling pathway; e.g., 
phosphorylated-Lck and phosphorylated-ZAP-70. These become polarized to areas of close 
membrane apposition with target cells where mature immunological synapses will form later. 
Membrane junctions between CD8+ T cells with target astrocytes display complex three-dimensional 
morphology; at times, T cells' membranes completely surrounds individual processes of target-
infected cells, or even insinuate their cell body directly into the target astrocyte's soma. 
Our experiments demonstrate that CD8+ T cells establish SMAC at immunological synapses with 
infected brain astrocytes that express MHC-I. The data shown herein demonstrate that the mature 
immunological synapses between T cells–APCs in vivo precede and mediate the clearing of virally 
infected astrocytes. In addition, we determined that nuclei of T cells formed an open arch toward 
the immunological synapse, a finding compatible with the known polarization of the microtubule 
organization center and Golgi apparatus of T cells toward the immunological synapse (32). 
The previous use of homogeneous populations of cloned T cells, APCs, and time-lapse confocal 
microscopy has allowed the detailed characterization of the kinetics of T cell–APC interaction and 
immunological synapse assembly and disassembly in culture (6, 8–12). Previous studies of T cell–APC 
interactions during in vivo immune responses could not demonstrate the formation of p- and c-
SMAC, as the result of limited resolution of microscopical techniques used (25, 33). Multiphoton 
laser scanning microscopy and confocal microscopy and other advanced imaging methodologies 
have made major contributions to our dynamic understanding of T cell–APC interactions in lymph 
nodes and other tissues in vivo (34). Although Kawakami et al. (33) used an ex vivo model to study 
the influx into the spinal cord of antimyelin CD4+ T cells and McGavern et al. (25) studied entry of 
CD8+ T cells into the meninges of lymphocytic choriomeningitis virus (LCMV)–infected animals, the 
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anatomical resolution of these studies precluded the morphological identification of SMAC 
formation in vivo (25, 33) (for a discussion on the status of visualization of immunological synapses 
in vivo, see reference 1, Section 7, page 407). 
That SMACs indeed form at immunological synapses during in vivo immune responses within the 
brain parenchyma during clearing of viral infections has hereby been demonstrated. Even if potential 
contacts between T cells and local APCs were described, the techniques used were unable to 
demonstrate the existence of SMAC formation during natural immune responses in the brain in vivo 
(1), thus not resolving the existence of SMAC formation as part of in vivo immunological synapse 
formation. 
We believe that the following factors aided in our capacity to detect SMAC formation in vivo in the 
context of a model antiviral immune response. First, we used an established model in which the 
kinetics of T cell influx contact with potential targets and elimination of transduced cells were all 
characterized in much detail. This allowed us to look for formation of immunological synapses at the 
time of peak T cell entry, but preceding the loss of transduced cells. Second, we used a replication-
defective virus expressing a marker gene. This allowed us to identify potential target cells by their 
expression of a marker gene, without viral replication compromising the survival of infected cells. 
Third, we optimized the perfusion of animals and our immunocytochemical protocol, in such a way 
to achieve best preservation of cellular structures through careful perfusion of experimental 
animals, and full and homogenous antibody penetration throughout the 50-μm-thick vibratome 
section, through careful improvements to the immunocytochemical protocols used. This allowed us 
to unravel the three-dimensional structure of interactions between T cells and the complex 
morphology of target brain astrocytes, and uncover sites of membrane apposition that would not 
have been found in thinner sections, or in the absence of complete antibody penetration. Fourth, we 
studied simultaneously the distribution of the essential markers that characterize SMAC formation in 
immunological synapses, and markers of the target cells, in combination within single sections using 
four-color immunostaining. Finally, the custom-made three-dimensional reconstruction software for 
confocal images allowed us to rotate cells in close anatomical appositions and observe the 
distribution of the several markers at different optical planes in a way that provides a complete 
picture of the distribution of immunological synaptic proteins in three full dimensions. This resulted 
in the typical “bull's eye” images of the mature immunological synaptic interfaces illustrated in Fig. 
8. 
Although the functional consequences of molecular segregation in the immunological synapse 
remain under investigation (16, 35), recent work has demonstrated that immunological synapses 
serve to channel cytokines and effector molecules toward target cells (18, 36). That mature 
immunological synapses were found in the brain preceding the clearance of viral infected cells, 
suggests that the presence of SMAC-containing immunological synapses in a physiological context in 
vivo may be necessary for clearance of virally infected cells to occur. However, the ultimate proof of 
this hypothesis will have to wait the development of compounds that selectively inhibit 
immunological synapse formation. 
The demonstration of mature immunological synapses in vivo during antiviral immune responses will 
allow further experimental exploration of immunological synaptic function during normal and 
pathological immune responses in vivo. Furthermore, this work should help contribute to settling 
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the controversy over the existence and functional significance of mature immunological synapses in 
vivo during antiviral immune responses. In summary, we propose that mature, SMAC-containing 
immunological synapses are the anatomical substrate that mediates the complex sequence of 
activation and effector function of T cells in vivo, as CD8+ T cells clear virally infected cells from the 
CNS. 
 
MATERIALS AND METHODS 
Animals, surgical procedures, viruses. 
Adult male Sprague-Dawley rats (250 g body weight) (Charles River) were used according to Cedars- 
Sinai Medical Center's Institutional Animal Care and Use Committee–approved protocols. 
Adenoviruses used in this study were first-generation E1/E3-deleted recombinant adenovirus 
vectors based on adenovirus type 5. The construction of RAdTK (expressing herpes simplex virus 
type I thymidine kinase, HSV1-TK) and RAdHPRT (expressing hypoxanthine-guanine phosphoribosyl-
transferase), all contain the hCMV promoter and have all been described in detail elsewhere (37). 
Animals were injected unilaterally in the left striatum with 107 infectious units (i.u.) of RAdTK in a 
volume of 1 μl and immunized 30 d later with 5 × 108 infectious units of RAdHPRT injected 
subcutaneously. Animals were killed for analysis at different time points after immunization as 
described in more detail in the following sections. 
Role of CD4+ and CD8+ T cells in clearing of adenovirally infected cells from the brain. 
75 animals were injected with 107 i.u. of RAdTK into the striatum at day 0. 1 mo later, rats were 
anaesthetized briefly and immunized subcutaneously in the back with 100 μl of either sterile saline 
(n = 15) or 5 × 108 i.u. of RAdHPRT (n = 60). 3 d after systemic immunization against adenovirus, one 
group of animals (n = 15) was injected weekly with 0.5 mg of OX8 monoclonal antibody i.p. to 
deplete CD8+ T cells. Another group (n = 15) was injected i.p. with 1 mg of OX34 monoclonal 
antibody every 2 wk to deplete CD4+ T cells, and two groups of animals were injected with mouse 
monoclonal irrelevant isotype antibodies as appropriate controls. The number of CD4+ and CD8+ T 
cells were quantified in draining cervical lymph nodes (Fig. S1). Results of the depletion studies are 
shown in Fig. 3. 7, 14, and 30 d after the immunization, five animals from each experimental group 
were killed via anesthetic overdose, transcardially perfused with 200–500 ml of oxygenated Tyrode 
solution, and spleen and cervical lymph nodes were removed for flow cytometry. Immediately 
afterward, animals were perfused/fixed with 4% paraformaldehyde to fix the brain. Brains were 
postfixed in 4% paraformaldehyde for up to 48 h, after which they were washed in phosphate buffer, 
cut into smaller tissue pieces, and sectioned as described in the following paragraph. This procedure 
provides excellent quality preservation of brain tissue for further analysis. For the CD8 depletion 
studies, postfixed brains were sectioned on a vibratome (Leica Instruments) at 50-μm section 
thickness. In the CD4 depletion studies, brains were cryoprotected in 20% sucrose and 16-μm 
sections were cut on the cryostat (Leica Instruments). 
Immunocytochemical procedures and confocal analysis. 
50-μm coronal brain sections were cut serially through the striatum on a Leica vibratome, and 
immunofluorescence or DAB detection was performed as described previously (20), using the 
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following primary antibodies recognizing: CD8 (1:500, mouse, Serotec), CD4 (1:100, mouse, Serotec), 
TK (1:10,000, rabbit, custom made), NeuN (1:1,000, mouse, Chemicon), GFAP (1:500, guinea pig, 
Advanced Immunochemical), phosphorylated Lck (1:50, rabbit, Cell Signaling), LFA-1 (1:500, mouse, 
IgG2a, BD Biosciences), TCR (1:100, mouse, IgG1, BD Biosciences), phosphorylated ZAP-70 (1:100, 
rabbit, Cell Signaling), and MHC-I (1:1,000, mouse, Serotec). Sections were examined using a Leica 
DMIRE2 confocal microscope (Leica Microsystems). Three-dimensional reconstructions to allow 
rotation of the images were rendered with α-blending software (custom made by K. Wawrowsky). 
Striatal sections from 25 animals were screened and analyzed in their whole extent searching for T 
cells interactions; a total of at least 60 immunological synapses (a likely underestimation of the total 
number of synapses present in the brain) at various stages of development were recorded and 
analyzed in detail. 
Note that given the complexity of the confocal analysis, the number of total immunological synapses 
illustrated throughout the manuscript in detail demonstrates the existence of immunological 
synapses in vivo, but obviously cannot be considered a faithful estimation of their total number. 
Currently, it remains technically impossible to record accurately the exact number of mature 
immunological synapses present in vivo. 
To determine the approximate number of activated T cells over the total number of T cells, the 
expression of phosphorylated ZAP-70, a marker of T cell activation after TCR engagement, and thus, 
a close surrogate of potential immunological synaptic engagement, was quantified. This analysis 
indicated that 75.4% of all CD8+ T cells within the injected striatum express phosphorylated ZAP-70. 
This provides a quantitative estimate of the potential frequency of immunological synapses being 
established by T cells. 
Confocal analysis. 
The brain sections were examined using a Leica DMIRE2 confocal microscope with the 63x oil 
objective and Confocal Software (Leica Microsystems). A series range for each section was 
determined by setting an upper and lower threshold using the Z/Y Position for Spatial Image Series 
setting, and confocal microscope settings were established and maintained by Leica and local 
technicians for optimal resolution. Contacts were defined as areas where colocalization of both 
markers occurs between two cells in at least two 0.5-μm-thick optical sections. Contacts can also be 
illustrated as they appear throughout the stack of sections as a simple 0.5-μm layer or as a 
transparency of all layers merged together. Relative fluorescence intensity along the plane of the 
immunological synaptic interface was measured with the Leica confocal software and is illustrated in 
the figures with corresponding arrows traversing the measured optical planes. 
Three-dimensional reconstructions where generated with a custom-made software. Images were α-
blended to perform a three-dimensional reconstruction from the two-dimensional serial images. The 
images were rotated in three-dimensional perspective to get the optical plane of the interface. The 
criteria of choosing the interface are illustrated in detail in Fig. 9. Artistic renderings (made by C. 
Barcia) were produced based on the three- dimensional analysis for Figs. 4 B and 5 B. 
Neutralizing antibody assay. 
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Adenovirus neutralizing antibody titers were measured in serum samples as described by us (20, 38) 
(Fig. S1). 
Real-time quantitative PCR analysis. 
12 rats were injected bilaterally into the striatum with 107 infectious units of RAdTK. 1 mo later, six 
animals were control immunized with saline, and six animals were immunized intradermally with 
RAdHPRT. Rats were killed 60 d after the immunization by neck dislocation and decapitation, after 
an anesthetic overdose. Brains were removed, cut into five blocks (left and right forebrain, left and 
right midbrain, and cerebellum), snap frozen in liquid nitrogen, and stored at −80°C. Frozen blocks of 
the left or right forebrain (containing the striatum) were ground to a fine powder under liquid 
nitrogen. DNA was extracted from 50 mg of ground tissue using spin columns for DNA purification 
(QIAGEN). 250 ng of DNA, or a quantity of cDNA corresponding to 100 ng of total RNA was amplified 
by PCR using TKf 5′-CGAGCCGATGAC TTACTGGC-3′ and TKr 5′-CCCCGGCGGATATCTCAC-3′ primers 
and the FAM-labeled TKp 5′-TACACCCAACACCGCCTCGACC-3′ TaqMan probe (PerkinElmer). RNA 
control was performed using two primers and a VIC-labeled 18S ribosomal probe (PerkinElmer). The 
TK copy number standard curve was obtained using dilutions of the previously described EpTK 
plasmid. The final concentration was 0.2 μM for each primer, probe 0.2 μM, dNTP 0.2 mM (except 
for dUTP 0.4mM), MgCl2 5 mM, UNG 0.5U in PCR buffer in the presence of 1.25 U of AmpliTaq Gold 
polymerase (PCR core reagents, PerkinElmer). DNA determinations were made in triplicate. 
Amplifications used a ABI Prism 7700 sequence detection system (PerkinElmer) with an initial step at 
50°C for 2 min, 95°C for 10 min, followed by 40 cycles of the following: denaturation at 95°C for 15 s 
and annealing/extension at 60°C for 1 min. Raw data were analyzed using the SDS v1.6.3. software 
(PerkinElmer). 
Statistical analysis. 
Viability data were expressed as mean ± SEM and evaluated by two- or one-way analysis of variance 
(followed by Dunnet or Tukey multiple comparisons tests). Differences were considered significant if 
P < 0.05. When significance testing using analysis of variance was not applicable, the Kruskal-Wallis 
nonparametric test was used instead. 
Online supplemental material. 
Fig. S1 illustrates neutralizing antiadenoviral antibody titers in immunized and nonimmunized rats, 
and levels of CD4+ and CD8+ T cells in cervical lymph nodes of naive and immunized rats. Fig. S2 
illustrates the effects of specific depleting antibodies on levels of CD8+ and CD4+ T cells in the 
spleen. The supplemental Materials and methods section includes detailed descriptions of 
immunocytochemistry and its stereological quantification. Online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20060420/DC1. 
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kinase. 
 
NOTES 
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FIGURE LEGENDS 
FIGURE 1: The systemic immune response clears infected astrocytes and virus genomes from the 
brain. (A) Virally infected cells are astrocytes. To determine the cellular nature of infected cells, 
confocal microscopy of triple immunolabeling of TK, a marker of adenovirus infection (green); GFAP, 
an astrocyte marker (magenta); and NeuN, a neuronal marker (red), was performed in 50-μm thick 
vibratome sections from the brains of animals studied 30 d after intracranial injection of virus, in the 
absence or presence, of systemic immunization. The top row illustrates TK, GFAP, and the merging of 
both images as indicated. The vast majority of the TK-immunoreactive cells were also GFAP+ (i.e., 
>85%). Some of the cells expressing both markers are indicated by white arrows on all three panels 
(all the TK-immunoreactive cells illustrated in these panels also expressed GFAP). The bottom row 
shows the same field, but colocalization was studied between TK and NeuN; no colocalization was 
detected. This indicates that the virus used expresses its marker gene almost exclusively within 
astrocytes, but not neurons. Bar, 100 μm. (B) Systemic immunization induces an immune response 
that clears virally infected expressing astrocytes and viral genomes from the brain. Panels a–e 
illustrate that after the systemic immunization against adenovirus, the adaptive immune response 
clears virally infected cells from the striatum. Analysis of brain sections from immunized animals (c, 
low power, and d, high power) show a reduction in the expression of the virally encoded marker 
gene, TK, when compared with naive animals (a and b). The decrease in the number of infected cells 
after immunization was assessed by quantifying adenovirally infected, TK-expressing cells (e), and 
the decrease in the number of viral genomes was quantified using quantitative real-time TaqMan 
PCR (f). Decreases in the number of infected cells (e), and adenoviral genomes (f), after the systemic 
immunization against adenovirus was statistically significant (*, P < 0.05; Student's t test). This 
indicates that the systemic immune response clears transduced astrocytes and viral genomes from 
the brain. Bars, 1 mm. (C) Adenovirally infected astrocytes express MHC-I. These panels illustrate a 
GFAP-immunoreactive astrocyte that has been infected with adenovirus and thus is immunopositive 
for the marker protein TK, expressing MHC-I. Bar, 40 μm. 
FIGURE 2: Anatomical localization of brain CD4+ and CD8+ T cells during the clearing of virally 
infected cells. CD4+ T cells within the brain remained immediately adjacent to brain blood vessels in 
the striatum (a and b), whereas CD8+ T cells (red) infiltrated the brain parenchyma proper (c and d). 
Time course studies (see Fig. 3) indicated that peak brain numbers of T cells were reached at 30 d for 
CD4+ T cells (b), and at 14 d for CD8+ T cells (d). Panels e and f illustrate that brain-infiltrating CD8+ T 
cells (red) within the rat striatum 7 and 14 d after immunization concentrate within the immediate 
vicinity of virally infected cells (i.e., TK-expressing cells *green+). Bars, 100 μm. CD8+ T cells establish 
close intercellular contacts with virally infected cells. CD8+ T cells were found surrounding virally 
infected (TK expressing) brain cells establishing multiple close contacts with them, especially at 14 d 
after immunization. Here, we illustrate two examples taken at 14 d after immunization. e and f 
represent confocal images throughout the thickness of the brain sections. Boxed areas in e and f are 
shown magnified to the right, but only a single 0.5-μm-thick optical section through the stacks 
shown in e and f is shown to demonstrate the close anatomical apposition between both cell types; 
xz and yz side views are illustrated too. White arrows indicate areas of close anatomical apposition 
of CD8+ T cells and infected no or very few brain cells. No or very few brain parenchyma–infiltrating 
T cells were detected in the hemisphere not infected with adenovirus or in the brains of injected 
animals that had not been immunized. Bar, 25 μm. 
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FIGURE 3: CD4+ and CD8+ T cells are necessary for viral clearance from the brain. (A) CD4+ T cells are 
necessary for clearance of virally infected cells from the brain parenchyma. There was no loss of 
virally infected cells in animals in which CD4+ T cells had been depleted during the systemic 
immunization against adenovirus (panel a; CD4+ T cells depleted rats: immunized + CD4-depleting 
monoclonal antibody OX34. Control nondepleted rats: immunized animals + control nonimmune 
antibody isotype). A peak in the number of CD4+ T cells within the striatum was detected at 30 d 
after immunization in nondepleted immunized animals, but not in immunized rats depleted of 
CD4+ T cells (b). As shown in Fig. 2, CD4+ T cells remained close to brain blood vessels. *, P < 0.05 
compared with nondepleted controls (nonparametric Kruskal-Wallis). (B) CD8+ T cells are necessary 
for clearance of virally infected cells from the brain parenchyma. No loss of virally infected cells 
could be detected in animals in which CD8+ T cells had been depleted during the systemic 
immunization against adenovirus (a; CD8+ T cell–depleted rats: immunized + CD8-depleting 
monoclonal antibody OX8. Control nondepleted rats: immunized animals + control nonimmune 
antibody isotype). A peak in the number of CD8+ T cells entering the brain parenchyma was detected 
at 14 d after immunization in nondepleted immunized animals, but not in immunized rats depleted 
of CD8+ T cells (b). As shown in Fig. 2, CD8+ T cells enter in the brain parenchyma proper and 
establish close appositions with virally infected cells. *, P < 0.05 compared with nondepleted 
controls (nonparametric Kruskal-Wallis). Rats that were injected with adenovirus in the brain, but 
were neither immunized nor injected with antibodies, were used as further controls and are 
illustrated in B. Notice that levels of infected, TK-immunoreactive cells in these animals did not differ 
from T cell–depleted rats (a). 
FIGURE 4: Polarized expression of p-Lck and p-ZAP-70 in CD8+ T cells tightly apposed to astrocytes 
during clearance of virally infected cells from the brain. Animals were infected unilaterally in the 
striatum with an adenovirus, and 30 d later they were immunized against adenovirus systemically. 
The systemic immunization induces a selective infiltration of CD8+ T cells into the injected, but not 
contralateral, hemisphere, which eventually clears infected astrocytes and viral genomes. All images 
shown represent 0.5-μm-thick confocal optical sections. Panels in A illustrate an activated 
lymphocyte in close anatomical apposition of the process of an astrocyte. Activation was established 
by p-Lck (green) immunoreactivity (a) within CD8+ (red) lymphocytes (b). Only CD8+ T cells that 
contacted astrocytes directly (GFAP+ processes) were immunoreactive for p-Lck, indicating the 
selective activation of T cells (a and b). White arrows indicate that the CD8+ T cell is contacting a 
GFAP-immunoreactive process (magenta) (c and merged images). DAPI nuclear staining (blue) was 
used as a cellular counterstain. Minimal T cells were observed within the noninjected hemisphere 
(not depicted). P-Lck within the CD8+T cells was polarized to the T cell's membrane in close contact 
with the astrocyte's process (white arrow in merged images). B represents a three-dimensional 
reconstruction of the contact illustrated in A; the confocal image of the contact area is shown in a; b 
illustrates the color scales for A and B, including colors of areas of overlap between fluorophores. C 
illustrates the polarized expression of phosphorylated ZAP-70 in several CD8+ T cells during the 
clearance of infected GFAP+ astrocytes from the brain; p-ZAP-70 (green), CD8 (red), GFAP (magenta 
or white), and DAPI (nuclear marker in blue). Note that ZAP-70 is polarized to the site of contact 
between the CD8+ T cell and the astrocytes' processes. Bars, 15 μm. 
FIGURE 5: Multiple sites of polarized accumulation of p-Lck in a CD8+ T cell establishing several 
contacts with a target astrocyte. (A) Confocal images of a CD8+ T cell that displays three areas of 
close membrane apposition to an astrocyte. (a–c) A stack of sections representing approximately a 
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total of 20 μm. (a) The immunoreactivity of the CD8+ T cell for p-Lck indicating three areas of p-Lck 
polarization (white arrows 1, 2, and 3 in a). b illustrates CD8-immunoreactivity and c shows the 
immunoreactivity of the target astrocyte for GFAP. The merged image (d) represents a single 0.5-μm 
optical section in which all three individual channels shown in a–c have been merged, with the 
associated xz and yz lateral views, to illustrate two intercellular contacts that are indicated by the 
white arrows labeled 1 and 2. Bar, 25 μm (B) The three-dimensional reconstruction, in detail, of the 
immunological synapses shown in A. (a) The merged image of the three individual stacks shown 
individually in A. Panel a has been rotated ∼35° to the left to clarify the view of two of the close 
appositions; these have been reconstructed in three dimensions and are shown at higher 
magnification in b–g. Within the three-dimensional reconstruction, the location of two close 
contacts is indicated by the broken circles 1 and 2. Close contact 1 is shown in b, d, and e in more 
detail. Panel b is the contact 1 of the three-dimensional reconstruction, from which a slice of the 
image has been removed to demonstrate the polarization of p-Lck (green) to the area of close 
apposition between both cells. Notice how the CD8+ T cell appears to engulf the GFAP process 
(magenta). An enlarged confocal image of the close contact is illustrated in d, whereas e is a contour 
map of each of the immunoreactivities illustrated in d. Panels c, f, and g illustrate the same analysis 
for contact number 2. Notice how the CD8+ T cell appears to form protrusions into the GFAP process 
of the astrocyte (magenta) (c, f, and g). 
FIGURE 6: Homogenous distribution of LFA-1 and TCR immunoreactivity along the plasma 
membrane of T cells not in contact with infected target cells.LFA-1 and TCR show homogeneous 
distribution along the plasma membrane of T cells neither in close apposition of target infected cells, 
nor involved in the formation of immunological synapses. Top panels (A–E) show a LFA-1 positive cell 
(B) not in contact with a TK-immunoreactive process (D), showing a uniform distribution of LFA-1. 
Panels F-J show a T cell with no LFA-1 expression (G) with a homogeneous distribution of TCR (H). 
Panels K-O show a T cell expressing LFA-1 (L) and TCR (M) not contacting a TK positive cell (N) 
showing no specific polarization and distribution in clusters. Panels P–T illustrate a CD8+ T cell 
expressing LFA-1 in a nonpolarized fashion in a cell that does not contact any infected cell. Bar, 25 
μm. 
FIGURE 7: Formation of c-SMAC and p-SMAC in vivo. TCR polarization and clustering within c-
SMAC (A) and LFA-1 distribution to the p-SMAC (B). TCR staining is polarized to membrane areas 
displaying close contacts between T cells and infected brain cells, and clusters at sites where 
immunological synapses form (two different immunological synapses are shown in A and C). Three-
dimensional reconstructions allow visualization of the formation of c-SMAC at the interface of 
lymphocytes and infected cells (A, under “Interface”); the quantification of the clustering of the TCR 
at the c-SMAC of the immunological synapses shownin A is illustrated in C (yellow arrow and 
intensity graph). LFA-1 forms a ring (p-SMAC) that surrounds c-SMAC, but is reduced within c-SMAC 
itself (two different immunological synapses are shown in B and D). Three-dimensional 
reconstructions show the LFA-1 immunoreactive p-SMAC ring at the interface between the T cells 
and target infected brain cells (B, under “Interface”); the quantification of the distribution of LFA-1 
immunoreactivity at the p-SMAC of immunological synapses shown in B is illustrated in D (yellow 
arrow and intensity graph). Bars, 25 μm. 
FIGURE 8: SMAC formation at immunological synapses in vivo, between T cells and infected 
astrocytes in the brain. Two mature immunological synapses displaying typical and characteristic 
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SMAC formations, are shown in A and B. The row of upper panels in A and B illustrate images 
captured in the given channels, from left to right: DAPI (blue), LFA-1 (red), TCR (green), LFA1+TCR, 
LFA1+TCR+DAPI (MERGE 1), the virally infected cell (TK; in white), and LFA1+TCR+DAPI+TK (MERGE 
2). Notice that these mature immunological synapses are characterized by the specific distribution of 
LFA-1 and TCR contacting the virally infected cell. In the views shown in the top panels (side views of 
the immunological synapses), LFA-1 immunoreactivity displays high relative fluorescence density 
within areas of the membrane lateral to the close apposition of membranes of the lymphocyte with 
the infected cell, thus displaying the typical central region of lower density (see arrows in red 
channel) at the site of highest density of immunoreactivity for TCR (see arrows in the green channel 
and in the MERGE 1 and 2 images). The yellow asterisk indicates, in the white channel, the 
anatomical location of the T cell. The row of bottom panels in A and B illustrate, respectively, low (a) 
and high (b) magnifications of the close apposition between the T cell and the infected cell. These 
images were reconstructed using three-dimensional visualization software to illustrate the 
characteristic structure of the p-SMAC (LFA-1 ring) and c-SMAC (TCR cluster) at the interface of the 
immunological synapses seen in en face views (c and d). To produce the three-dimensional image of 
the interface shown in c and d, the three-dimensional reconstruction was rotated so that the plane 
of the interface of the immunological synapse (b, broken arrow) could be observed from above 
(white arrow in b shows the angle of vision of c and d). At the interface, typical “bull's eye” 
structures, characteristic of p-SMAC (LFA-1 outer ring) and c-SMAC (central TCR cluster) can be 
clearly recognized (c and d). In C, the intensity of fluorescence (I) was measured at the interface 
(yellow line) of the immunological synapse in a 0.5-μm confocal layer taken through the interface. 
The small graphs to the right of each synapse show the relative intensity values of fluorescence of 
LFA-1 (in red) and TCR (in green). Note the maximum of intensity for LFA-1 was in the periphery of 
the synapse (p-SMAC), whereas the TCR is clustered toward the center (c-SMAC). (D) A diagrammatic 
view of a T cell contacting an antigen-expressing astrocyte illustrating the localization of molecules 
involved in the immunological synapse and the polarization and phosphorylation of key tyrosine 
kinases. (E) A characteristic activated T cell nucleus displaying the polarized arched conformation 
opening toward the immunological synaptic interface. Bars, 15 μm. 
FIGURE 9: Criteria used in the selection of optical planes from three-dimensional reconstructions 
of mature immunological synapses, for the illustration of SMAC formation in vivo. 90° rotations of 
three-dimensional reconstructions were made to observe the xz optical planes 1, 2, and 3 through 
axis y. Images A1, A2, and A3 show xz optical planes from image A. The immunological synaptic 
interface seen in optical plane xz (1) is illustrated in A1; this optical plane was selected as the one in 
which the T cell's nucleus could not be visualized. Optical planes 2 and 3 (illustrated in A2 and A3) 
show the T cell's nucleus, demonstrating that these optical planes are at a distance from the synaptic 
interface and thus do not allow observation of the SMAC. Note that the optical plane 1 is the only 
one that shows the SMAC. yz optical planes 4, 5, and 6 were obtained from a 90° rotation of image B 
through the x axis. In plane 5 (illustrated in A5) the TCR is closely apposed to the infected cell 
without any intervening LFA-1; this plane is taken through the center of the c-SMAC. In images of 
planes 4 and 6 (illustrated in A4 and A6) LFA-1 immunoreactivity, rather than TCR, is in close 
apposition of the infected cell, indicating that these planes are taken through the p-SMAC. Note that 
this detailed three-dimensional reconstruction analysis was performed on the synapse illustrated in 
Fig. 8 A. 
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FIGURE 10: Quantitative distribution of LFA-1 through the plasma membrane of T cells involved in 
formation of mature immunological synapses. The relative fluorescence of LFA-1 was measured in 
six T cells forming mature immunological synapses contacting virally infected cells (A). The red LFA-1 
channel was selected [B] and the complete distribution of LFA-1 throughout the extent of the plasma 
membrane was delineated measuring the intensity of fluorescence in a linear graph (illustrated 
schematically in C). Panels D–I show the quantification of LFA-1 in six different cells forming mature 
immunological synapses. Small white arrows ‘1’ and ‘3’ indicate the p-SMAC and arrow ‘2’ the c-
SMAC. Note that the level of LFA-1 is reduced (or absent) within the c-SMAC of all cells. Further LFA-
1 levels are increased in the p-SMAC in some cells (illustrated in D, G, and I), while it does not 
increase in the p-SMAC of others [F, H, E]. Note that for clarity the target virally infected cells, found 
in apposition of the immunological synapses illustrated, are not shown; synapses shown in (D) and 
(E) are illustrated in further detail in Fig. 7, and synapse (F) in Fig. 8 A. Synapses H, G, and I are not 
illustrated further.  
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SUPPLEMENTARY MATERIAL 
SUPPLEMENTAL METHODS 
Immunofluorescence. 
Immunocytochemical detection methods were optimized during preliminary experiments to achieve 
full and homogenous antibody penetration throughout the total thickness of vibratome sections. 
Adjacent 50-μm thick sections of each brain were pretreated with citrate buffer during 30 min at 
60°C to increase antigen retrieval and penetration of the antibodies into the tissues. Sections were 
blocked with 1% Triton X-100 for 5 min and 3% normal horse serum in 0.1 M PBS, pH 7.4, for 60 min. 
The sections were incubated at room temperature for 48 h with primary antibodies combined. In the 
double or triple staining, the incubation with primary antibody was followed by 4 h of incubation 
with the appropriate secondary antibodies. Alexa 488–conjugated goat anti–rabbit antibody  
1:1,000; Invitrogen), Alexa 594-conjugated goat anti–rat IgG antibody (1:1,000; Invitrogen), Alexa 
594–conjugated goat anti–mouse IgG antibody (1:1,000; Invitrogen), Alexa 647–conjugated goat 
anti–guinea pig IgG antibody (1:1,000; Invitrogen), RRX goat anti–mouse IgG2a (1:500; Jackson 
ImmunoResearch Laboratories) or FITC-goat anti–mouse IgG1 (1:500; Jackson ImmunoResearch 
Laboratories). After washing, sections were incubated with DAPI solution for 30 min. Sections were 
washed, mounted, and examined with a microscopy for normal fluorescence (Carl Zeiss 
MicroImaging, Inc.) and analyzed with the confocal microscope (Leica). 
DAB detection of immunocytochemistry. 
Serial sections were used to detect transgene expression. Endogenous peroxidase activity was 
quenched with 0.3% H2O2 in PBS, nonspecific Fc binding sites were blocked with 10% horse serum, 
and sections were incubated for 48 h at room temperature with primary antibody diluted in PBS 
containing 1% horse serum and 0.5% Triton-X-100 (antibody solution). Sections were incubated for 4 
h with biotin-conjugated appropriate secondary antibodies (DakoCytomation). Antibody binding was 
detected using avidin-biotin peroxidase with diaminobenzidine as chromogen, the glucose-oxidase 
system as a generator of H2O2, and intensification with Ni. These sections were mounted on 
gelatinized glass slides and were dehydrated before coverslipping. 
Quantification of immunohistochemical staining. 
Quantitative image analysis to estimate numbers of TK-, CD8+-, and CD4+-immunoreactive cells 
were performed with specific stereology software (StereoInvestigator) using a computer-assisted 
image analysis system with a Zeiss microscope connected to a digital camera through a zoom set 
(Carl Zeiss MicroImaging, Inc.), as described by us previously (39). The stereological estimation of the 
number of CD8 and TK immunoreactive cells was performed in the striatum and external capsule 
overlying the striatum, and anatomical locations were identified according to the atlas of the rat 
brain in 50-μm brain sections spaced at regular 250-μm intervals, as described in detail by us 
previously (Dewey, R.A., G. Morrissey, C.M. Cowsill, D. Stone, F. Bolognani, N.J. Dodd, T.D. 
Southgate, D. Klatzmann, H. Lassmann, M.G. Castro, and P.R. Lowenstein. 1999. Nat. Med. 5:1256–
1263; Suwelack, D., A. Hurtado-Lorenzo, E. Millan, V. Gonzalez Nicolini, K. Wawrowsky, P. 
Lowenstein, and M.G. Castro. 2004. Gene Ther. 11:1742–1752). The estimation of the number of 
cells was performed using the principle of the optical fractionator. The number of cells was 
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measured in 200-μm-sided dissectors covering the whole surface area of the analyzed regions (50 
counting frames in each section). Results were expressed as absolute number of positive cells in the 
anatomical regions analyzed. Data are expressed as the means ± SEM. 
SUPPLEMENTAL FIGURE LEGENDS 
FIGURE S1. Systemic immunization against adenovirus increases the circulating titer of neutralizing 
antibodies against adenovirus and increases the number of CD4+ and CD8+ T cells in cervical lymph 
nodes draining from the brain. To demonstrate the presence of neutralizing antibodies against 
adenovirus after systemic immunization against adenovirus, antibody titers were measured in two 
different groups of immunized animals (either treated with OX8 antibody or treated with control 
irrelevant antibody isotype). Both these groups of animals, but not naive, nonimmunized animals 
(A), showed a significant increase in levels of circulating antiadenovirus antibodies. We observed an 
increase in the numbers of CD4+ and CD8+ T cells (detected by flow cytometry) in cervical lymph 
nodes in animals that had been injected with adenovirus into the brain and immunized systemically 
against adenovirus, compared with control animals that had been injected with virus in the brain, 
but had not been immunized (B and C). *, P < 0.05, Student’s t test. 
FIGURE S2. Verification of systemic depletion of CD4+ and CD8+ T cells in animals injected with the 
respective depleting antibodies. A statistically significant reduction of CD8+ T cells (A) or CD4+ T cells 
(B) was observed, by flow cytometry, in the spleens of animals depleted of either CD8+ T cells, 
through administration of OX8, or depleted of CD4+ T cells, through administration of OX34, 
respectively. *, P < 0.05 was the value for the statistical significance of the difference between 
immunized and depleted animals, compared with controls (nonparametric Kruskal-Wallis). 
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